Postes actifs de Bruno Ohana
Sociétés | Poste | Début | Fin |
---|---|---|---|
biologit
biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Directeur Technique/Scientifique/R&D | - | - | |
Fondateur | - | - |
Historique de carrière de Bruno Ohana
Statistiques
Internationale
Irlande | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
biologit
biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Technology Services |
- Bourse
- Insiders
- Bruno Ohana
- Expérience